CROI 2024 Abstract eBook

Abstract eBook

Search Term Index

Conditional economic incentives 1244 Condom 1028, 1250 Congenital syphilis 930, 1159, 1160 Connectomics 585 Contact 877 Contact tracing 1063 Contraception 1163 Contraceptive 605, 1173 Control 319 COPD 827 CoRIS 1081 Coronary 795 Coronary artery disease 772 Coronaviruses 673 Cortisol 855 Cosmetic injectables 191 Cost 1105, 1232 Cost-effectiveness 1083, 1229, 1230, 1231, 1234, 1251 Cost modeling 704 Counseling 652, 1113 COVID-19 132, 133, 145, 199, 339, 344, 392, 393, 395, 396, 559, 559, 560, 568, 604, 657, 659, 661, 662, 663, 667, 668, 669, 670, 671, 730, 846, 850, 856, 859, 863, 864, 868, 868, 996, 1008, 1012, 1014, 1073, 1075, 1080, 1208, 1212 COVID-19-associated 1077, 1207, 1211 COVID-19 mortality 664, 665, 1055, 1076 COVID-19 pandemic 1055, 1072, 1077 COVID-19 severity 338, 343, 858, 860, 862, 863 COVID-19 testing 860, 1083, 1095 COVID-19 vaccine 385, 392, 393, 395, 396, 399, 673, 730, 851, 857, 1095, 1209, 1210 CRAg 893 Creatinine 830 Criminal legal involved 1095 CRISPR-Cas9 142, 538 CRISPR screen 142 Cross-reactivity 384 Crosstalk 454 Cryotherapy 763 Cryptococcal 322, 887 Cryptococcal antigen 890, 893 Cryptococcal meningitis 876, 885, 886, 887, 888, 893, 894 Cryptococcosis 888 CSF 580, 885 CT coronary angiogram 772 Cure 175, 446, 493, 530 Cure strategy 180, 459, 534, 538 CVD 779, 783, 784 CX3CR1 334 CXCR4 453 Cycle threshold 959 Cyclosporine 429 Cystatin C 830 Cytokine 449, 518 Cytokine production 437, 448 Cytokines 338, 356, 360, 434, 536, 776 Cytomegalovirus 319, 320, 322, 354, 602, 955, 962, 975 Cytoskeleton 174 Cytotoxic response 440 Cytotoxic T lymphocytes 174, 414, 497, 951 D-dimer 837, 867

1051 DEXA 948 Diabetes 797, 801, 802, 805, 971 Diabody 414 Diagnosis 193, 897, 1040, 1104 Diagnostic test 895, 1089 Diet 342, 810 Differentiated service delivery 204, 1195, 1217, 1229, 1246, 1247, 1248, 1252 Difficult-to-treat HIV 1047 Diffuse large B-cell lymphoma 758 Dimethylarginine 924 Direct-acting antiviral 696, 698, 715, 716, 717 Directly observed therapy 697, 901 Disclosure 920 Discontinuation 1123 Discrete choice experiment 1244 Disengagement 1041, 1199 Disparities 755, 1228 DMPA 824 DNA methylation 593, 970 Dolutegravir 156, 186, 187, 553, 556, 557, 606, 645, 648, 655, 675, 676, 677, 678, 680, 683, 803, 808, 811, 878, 905, 910, 911, 916, 918, 921, 922, 925, 937, 938, 941, 944, 945, 981, 982, 984, 986, 987, 988, 1137, 1182 Dolutegravir/lamivudine 693, 810 DOMINO 634 Doravirine 605, 694, 807 Douche 612 Doxycycline 124, 125, 611, 1149, 1150, 1151, 1153 DoxyPEP 127, 1148, 1153, 1154 DREAMS 1217 Dried blood 1091 Dried blood spot 609, 1121 Drug 478 Drug-drug interaction 605, 1144, 1145, 1146 Drug concentrations 608, 869 Drug discovery 303 Drug interactions 429, 604 Drug overdose 1005 Drug resistance 136, 185, 675, 676, 677, 691, 983, 1099 Drug resistant TB 872, 897 Drug safety 805, 932

Endothelium 567, 774, 777 Enema 364 Engagement 991, 1219 Enrollment 1181

Gestational diabetes 911 GHESKIO 641

GI tract 325, 499 Glecaprevir 161 Glecaprevir/pibrentasvir 161 Glial fibrillary acidic protein 546, 598 Glucose 785 Glucose disposal 785 Glutathione 578 Glycan 103 Glycolysis 578

Ensitrelvir 604 Enterocyte 806 Env 371, 527, 688 Envelope 580

Envelope glycoprotein 368, 371, 537, 685 Epidemiology 196, 396, 765, 875, 1042, 1045, 1054 Epigenetic 324, 355, 593, 594, 970

Glycomic 359, 549 Glycoprotein 306 Gonorrhea 1150 GPS 1025 Granzyme B 335 Griffithsin 674 Growth 986

Epigenetic age 355, 595 Epithelial barrier 1168 Equity 621, 1183 ERAP2 401 Escape 528, 574, 887 Established reservoir 519

Estrogen 359 Ethnicity 742 Evaluation 1194 Event-driven PrEP 1195 Event driven 1190 Evolution 367, 371, 1068 Executive function 109, 548 Exercise 838 Exhaustion 471, 718 Exposure-response analysis 944, 945 Extended therapy 420

Growth curve 963 GSK3640254 634 Gut 332, 334, 335, 336, 500, 501, 744 Gut barrier 342 Gut microbiome 919 GWAS 319 Hair concentration 998 Haiti 641 HAND 571, 576, 591, 599, 603

Harm reduction 160 Harmonization 940

Factor 1057 Failure 645 False negative 1104 False positive 959

HBcrAg 733 HBeAg 732 HBsAg 162

HBsAg-specific B cells 738 HBsAg loss 733, 737, 738 HBV 727, 729, 731, 732, 734, 736, 737, 739, 741 HBV RNA 733, 734, 741 HCC 726 HCV 323, 699, 701, 703, 705, 708, 712, 713, 718, 719, 720, 722, 723, 1011 HCV care cascade 701, 705, 707 HCV care continuum 705, 708, 709 HCV testing 707, 1090 HCV therapy 161 HCV treatment 160, 696, 697, 708, 709, 711 HCV viremia 698 HDACi 957 Health care 1008, 1050 Health care workers 390 Health coverage 1006 Health disparity 192, 786, 923, 1019, 1050 Health equity 1116 Health policy 1092 Health promotion 1227 Heart failure 792, 794, 796 Hematologic 670 Hepatic decompensation 726 Hepatic steatosis 158, 159 Hepatitis 162 Hepatitis B virus 162, 209, 725, 728, 730, 733, 734, 736, 740 Hepatitis C virus 696, 697, 702, 704, 705, 708, 710, 715, 716, 717, 721 Hepatitis D virus 162, 724, 725, 726, 735 Hepatocellular carcinoma 716, 717, 725 Hepcidin 600 Herpes simplex virus 322, 345, 1168 Herpes zoster virus 345 Heteroplasmy 582 Heterosexual 200, 1010, 1118 HEU 963 High resolution anoscopy 760 High risk 1165 Hispanic/Latino 1017 Histone deacetylase inhibitor 173, 477 Histoplasma 890 Histoplasmosis 895 HIV 105, 111, 115, 129, 133, 143, 144, 151, 178, 191, 192, 193, 202, 203, 323, 331, 369, 377, 384, 414, 427, 430, 435, 441, 451, 452, 494, 526, 545, 555, 566, 572, 573, 581, 583, 587, 589, 592, 599, 623, 642, 675, 681, 695, 699, 720, 725, 728, 733, 749, 756, 758, 768, 773, 779, 782, 813, 824, 837, 839, 842, 846, 864, 876, 883, 913, 917, 921, 926, 927, 948,

Family planning 1092 Fanconi syndrome 828 Fast-track 1224 Fast sequencing 1099 Fat mass 865 Fatty liver 158, 159 Fatty liver disease 158, 159, 746 Favipiravir 667 Fc 411 Fc-effector functions 393 Feasibility 621, 1167 Female 1027 Female genital tract 432, 1176 Female sex workers 1120, 1140, 1176 Fibrosis 158 Fiebig staging 514 Fishermen 1223 Fitness 304 Fixed-dose 944 Fixed-dose combination 945 Flow cytometry 437, 449, 471, 770 Food insecurity 923 Formative session 1081 Frailty 152, 355, 595, 601, 836, 838, 839, 840 FTC/TDF PrEP 170 Full-length polymerase 1099 Full-length sequencing 486, 492 Functional cure 738 Functional genomics 778 Functional PCA 1038 Fungal infection 895 Fusion peptide 369 Gag-NC 685 Galectin-3 832 Gamma delta T cell 334, 438 Gay and bisexual men 166, 200, 1010 Gay men 1169 Gender 1020, 1053 Gender-affirming 536, 1144, 1145, 1146, 1175 Gene expression 469 Gene profile 780

Drug use 1005 DTG 790, 983 DTG/3TC 946

Dual prevention pill 1139 Dual therapy 736, 813, 946

Duodenum 806 Durability 424 Dyslipidemia 802 Early ART initiation 468, 470, 513, 514, 516,

517, 649, 753, 956, 964, 1181 Early bactericidal activity 157 Early infant diagnosis 960 East Africa 1068 Ebstein-Barr virus 602 eCD4-Ig 177 Echocardiography 873

Search Term Index

Economic 1233 Education 1095 Efavirenz 553, 556, 808, 812, 905, 910, 918, 922, 937, 938 Effectiveness 166, 661, 1210, 1236 Effectiveness and safety 869 Electronic health record 1075 Electronic medical record 1238 ELISA 518 ELISpot 447, 750, 953 Elite controllers 361, 447 Emergency 1051 Emergency department 205, 707, 708, 990, 1051, 1160 Emtricitabine 1100, 1141 Ending the HIV Epidemic 1177, 1183 Effector function 534 Efficacy 117, 208, 874 Elderly 616, 857

DAA 698, 718 Dapivirine 168 Darunavir 814 Dasatinib 841 Data 1213 Database 688 Decentralization 702 Defective proviruses 462, 467 Delivery 538 Dementia 603

Gene therapy 520, 533 Genetic diversity 1068 Genetic signature 476 Genetic variation 380, 870 Genital tract 1168

Dendritic-cell targeting 382 Dendritic-cell therapy 443 Dendritic cells 305, 340 Depletion 335 Depression 110, 553, 573, 582, 594, 834, 835, 851, 921, 923, 1049, 1050, 1051 Depressive symptom severity 110 Depressive symptoms 189, 582, 921, 1050,

Genome sequencing 463 Genomic surveillance 425 Geospatial 1025 Geospatial analysis 989, 1067 Germinal center 101, 325, 382, 406 Germline-targeting 381

Endocytosis 305 Endothelial 745 Endothelial activation 776 Endothelial cells 776

CROI 2024 440